Our Model
Historically, it could take 10 years and hundreds of millions of dollars to develop a treatment with a 5% chance of success. Today, we can design, develop, and treat a child with a rare genetic disease in as little as a year.
Our vision is to scale this transformative process, making effective treatments accessible to every child in need.
Our Strategy.
Built Around Patients
We innovate medicines, technologies, systems, and efficiencies with the speed and urgency needed to maximize patient access to treatments — because every moment matters. Time = Life.
Antisense Oligonucleotides
We utilize a proven genetic medicine platform that is highly targeted, enables rapid development, and supports affordable manufacturing.
AI
We harness the power of AI and machine learning to target the right genes, design better medicines, and reduce the time needed in preclinical and clinical development.
Get in Touch
We're Here to Help
Whether you have a project in mind, need guidance, or want to explore collaboration opportunities — reach out anytime. Our team will respond quickly and provide everything you need to move forward.
Time is life.
Every week that passes without treatment is a week a child's disease progresses. We don't have the luxury of moving at the pace of traditional biotech. Neither do they.